These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2932585)

  • 61. Antiherpes activity of the immunomodulator OK-432, a streptococcal preparation, in immunosuppressed mice.
    Ikeda S; Sai K; Nishimura C; Yamamoto A
    Antiviral Res; 1988 Dec; 10(6):299-304. PubMed ID: 2854959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
    Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Tumor growth inhibitory factor (S) produced by lymphocytes in cancer patients with long-term OK-432 therapy].
    Katano M
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2088. PubMed ID: 2432298
    [No Abstract]   [Full Text] [Related]  

  • 64. The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.
    Toge T; Kuninobu H; Yamaguchi Y; Baba N; Kegoya Y; Hattori T
    Jpn J Surg; 1988 Nov; 18(6):668-74. PubMed ID: 3266768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.
    Hanaue H; Kurosawa T; Yasuda H; Yoshizaki S; Nomoto SN; Takada T; Shikata J
    Keio J Med; 1984 Apr; 33(1):17-27. PubMed ID: 6482140
    [No Abstract]   [Full Text] [Related]  

  • 66. [Immunotherapy of gastric cancer].
    Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antitumor effect of the streptococcal preparation OK-432 in a murine model of ovarian cancer.
    Lichtenstein A
    Cancer Immunol Immunother; 1987; 24(2):172-7. PubMed ID: 3829052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Intraperitoneal administration of OK-432 and rIL-2 in a case of peritonitis carcinomatosa with chronic renal failure].
    Kanaoka Y; Umesaki N; Kawabata M; Tsuda H; Sugawa T
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1027-31. PubMed ID: 2391442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
    Hoshino T; Uchida A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
    [TBL] [Abstract][Full Text] [Related]  

  • 71. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
    Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus.
    Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y
    Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous intraperitoneal administration of OK-432 and serum enhances superoxide generation from migrated polymorphonuclear leukocytes, with special emphasis on the role of complements.
    Yoshikawa T; Takano H; Yoshida N; Kondo M
    Immunopharmacol Immunotoxicol; 1995 May; 17(2):265-82. PubMed ID: 7650290
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of intratumoral administration of OK-432 on breast cancer--analysis of T cell subsets of tumor infiltrating lymphocytes by using the immunohistological stainings--preliminary report].
    Hosokawa T; Haga S; Shimizu T; Iida T; Imamura H; Watanabe O; Kajiwara T
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):316. PubMed ID: 2787471
    [No Abstract]   [Full Text] [Related]  

  • 76. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
    [No Abstract]   [Full Text] [Related]  

  • 77. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).
    Katano M; Mizoguchi T; Yamamoto H; Nakamura M; Matsuo T; Hisatugu T; Kisu T; Yamaoka K; Tokunaga O
    Jpn J Surg; 1990 Jan; 20(1):76-82. PubMed ID: 2304290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 79. [Complications due to high-dose OK-432 administration into tumors and the peritoneal cavity in patients with advanced gastric cancer].
    Fukasawa K; Shiraishi M; Tachibana M; Utsumi Y; Nakamura T
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3365-8. PubMed ID: 3688897
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
    Wakida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.